Brief: BioScrip Inc Reports Q3 Loss of $0.09 Per Share

Option Care Health

06/11/2018 13:17

Nov 6 (Reuters) - BioScrip Inc  BIOS.O :
    * BIOSCRIP REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS
    * Q3 REVENUE $181 MILLION VERSUS I/B/E/S VIEW $171.1 MILLION
    * SEES FY 2018 REVENUE $710 MILLION TO $720 MILLION
    * QUARTERLY LOSS PER SHARE $0.09
    * SAYS MAINTAINING FY 2018 ADJUSTED EBITDA GUIDANCE BETWEEN
$54
MILLION AND $58 MILLION
    * SAYS REMAIN INCREASINGLY CONFIDENT THAT BIOSCRIP CAN
ACHIEVE AT
LEAST $75 MILLION IN ADJUSTED EBITDA IN 2019

Source text for Eikon:  ID:nGNX2YVc25 
Further company coverage:  BIOS.O 

 ((Reuters.Briefs@thomsonreuters.com;))